Sponsor or institution
Clinical trials and research at Universität des Saarlandes
As of November 12, 2026, Find a Trial lists 10 clinical trials run by Universität des Saarlandes that are recruiting, at sites in 2 countries (most in Germany (10), Switzerland (1)). By phase: Phase 3 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 2Countries
Newest trials
All recruiting trials (10)
-
5:2 intermittent fasting for MASLD
This trial will test whether eating normally five days and limiting intake to about 600 calories on two days each week helps adults with MASLD.
-
Re‑radiation with chemotherapy plus pembrolizumab versus pembrolizumab (± chemotherapy) for recurrent PD‑L1 positive head and neck cancer
This trial tests whether adding re‑radiation with chemotherapy followed by pembrolizumab helps people with PD‑L1 positive (CPS≥1) locoregionally recurrent head and neck cancer live longer than pembrolizumab alone (with or without chemotherapy).
-
Examining sex differences in prehospital stroke care
This study looks at how emergency medical services treat suspected strokes in men and women differently to see if there are any gaps in care that need to be addressed.
-
Combining durvalumab with radiochemotherapy and stereotactic radiotherapy for extensive-stage small-cell lung cancer
This study is testing if adding the immunotherapy drug durvalumab to radiochemotherapy and targeted radiation can help people with extensive-stage small-cell lung cancer feel better and manage their disease.
-
Evaluating a new biomarker for early kidney injury detection
This study is testing if a new urine test can help doctors spot early signs of kidney injury in critically ill patients before traditional tests do.
-
Combining Acalabrutinib with R-miniCHOP for older adults with untreated diffuse large B-cell lymphoma
This study tests if adding Acalabrutinib to the usual treatment for older adults with untreated diffuse large B-cell lymphoma can help them live longer without their cancer getting worse.
-
Observational study on the biology of COVID-19 in Saarland
This study looks at how COVID-19 affects people in different ways, including those with long-term symptoms, to learn more about the disease and its progression.
-
Longitudinal analysis of Keratoconus patients at the Homburg Keratoconus Center
This study looks at over 3,000 people with Keratoconus to see how the disease develops over time and to find ways to improve diagnosis and treatment.
-
Research on the causes of fatigue in cancer and chronic fatigue syndrome
This study is testing the causes of fatigue in cancer patients and those with chronic fatigue syndrome, while also seeing if probiotics can help reduce their tiredness.
-
Registry tracking corneal transplant trends in Germany
This study looks at how corneal transplants are being done in Germany, including the number of surgeries and the reasons for them, to better understand current practices and results.
Quick answers
How many clinical trials run by Universität des Saarlandes are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Germany (10 trials), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.